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Low-grade inflammation in fat is associated with in-
sulin resistance, although the mechanisms are un-
clear. We report that mice deficient in the immune
cell transcription factor T-bet have lower energy
expenditure and increased visceral fat compared
with wild-type mice, yet paradoxically are more insu-
lin sensitive. This striking phenotype, present in
young T-bet/ mice, persisted with high-fat diet
and increasing host age and was associated with
altered immune cell numbers and cytokine secretion
specifically in visceral adipose tissue. However, the
favorable metabolic phenotype observed in T-bet-
deficient hosts was lost in T-bet/mice also lacking
adaptive immunity (T-bet/xRag2/), demon-
strating that T-bet expression in the adaptive rather
than the innate immune system impacts host glucose
homeostasis. Indeed, adoptive transfer of T-bet-
deficient, but not wild-type, CD4+ T cells to Rag2/
mice improved insulin sensitivity. Our results reveal a
role for T-bet in metabolic physiology and obesity-
associated insulin resistance.
INTRODUCTION
Obesity is increasingly recognized to be associated with low-
grade inflammation in fat (Osborn and Olefsky, 2012). Initial
studies reported the accumulation of macrophages within adi-
pose tissue and the subsequent liberation of proinflammatory
cytokines such as interleukin-1 (IL-1), IL-6, and tumor necrosis
factor alpha (TNF-a), which contribute to obesity-associated in-
sulin resistance (Weisberg et al., 2003; Xu et al., 2003). Immune
cell infiltration in visceral fat is particularly associated with the
adverse metabolic complications of obesity. Recent work has
indicated a key role for T cells in this process (Feuerer et al.,
2009; Kintscher et al., 2008; Nishimura et al., 2009; Winer
et al., 2009). Indeed, infiltration of lymphocytes into fat typically
precedes that of macrophages by several weeks (Kintscher520 Cell Metabolism 17, 520–533, April 2, 2013 ª2013 Elsevier Inc.et al., 2008). However, although there is an increasing apprecia-
tion of the role of the immune system in the development of
obesity-induced inflammation, the molecular drivers of this pro-
cess are still poorly defined. Furthermore, immune cells are
already present in normal lean adipose tissue prior to the onset
of obesity. The role of adipose tissue immune cells in the regula-
tion of normal metabolic physiology, before the onset of obesity,
is unknown.
CD4+Tcell lineages includeThelper1 (Th1), Th2,Th17,and reg-
ulatory T cells (Tregs), which are instructed by the pattern of sig-
nals they receive during their initial interaction with antigen and
defined by the profile of their secreted cytokines (Zhu and Paul,
2008). In other chronic inflammatory conditions, such as athero-
sclerosis, there is a predominance of Th1 over Th2 cytokines
(Hanssonet al., 2002).Wepreviously showed that theadipose-tis-
sue-derived hormone leptin, which is increased in obesity, favors
the development of Th1 over Th2 T cells (Lord et al., 1998) and is
important in T cell development and survival (Howard et al., 1999).
Recent studies indicated thatobesity isassociatedwithaprogres-
sive bias toward a proinflammatory Th1 cell phenotype in fat,
which is associated with insulin resistance (Lumeng et al., 2009).
In obesity, the T cell population in adipose tissue is altered: proin-
flammatory Th1 T cell numbers substantially increase and there is
a decline in the proportion of anti-inflammatory Foxp3+ Treg cells
(Feuerer et al., 2009; Winer et al., 2009). T cells were recently re-
ported to influence glucose homeostasis in mice with diet-
induced obesity (Duffaut et al., 2009; Feuerer et al., 2009; Winer
et al., 2009). When used in immunotherapy, Tregs can reverse
obesity-associated insulin resistance.
Rag1/ mice lack an adaptive immune system (lymphocytes)
due to the absence of recombinase activating gene 1 (Rag1).
When fed a high-fat diet (HFD), these mice became more insulin
resistant than control mice, suggesting that lymphocytes protect
against the deleterious effects of obesity. Reconstitution with
CD4+ T cells in diet-induced obeseRag1-deficientmice improved
glucose toleranceandenhanced insulin sensitivity, although these
mice also lost weight (Winer et al., 2009). The molecular mecha-
nisms underlying these observations, however, remain unclear.
T-bet (Tbx21) is a T-box transcription factor family member
that regulates the differentiation and function of immune cells.
Expression of T-bet is almost exclusively confined to the immune
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Figure 1. T-bet-Deficient Mice Have
Increased Body Weight and Modified Fat
Distribution, Independently of Diet
(A) Body weights of WT and T-bet/ mice at
the start (8 weeks old) and after 20 weeks of LFD
and HFD.
(B) Cumulative food intake of WT and T-bet/
mice during the 20 weeks of LFD and HFD feeding.
(C) Weights of PG WAT, mesenteric fat pad (Mes
WAT), SC WAT, and the sum of these weights
(Total WAT) from WT and T-bet/ mice after
20 weeks of LFD and HFD (n = 12–17).
(D) Representative H&E staining of PG WAT
from WT and T-bet/mice after 20 weeks of LFD
and HFD.
(E) Adipocyte diameter measurement of PG WAT
from WT and T-bet/mice after 20 weeks of LFD
and HFD (n = 5).
(F) Fasting leptin levels in WT and T-bet/ mice
after 14 weeks of LFD and HFD (n = 10–15). Data
represent means ± SEM; *p < 0.05, **p < 0.01,
***p < 0.005. See also Figure S1.
Cell Metabolism
A Role for T-bet in Metabolic Physiologysystem, where it has a critical role in T cell lineage commitment
(Kanhere et al., 2012). Indeed, T-bet is the key lineage-defining
transcription factor that directs the development Th1 cells and
is directly responsible for the transactivation of the interferon-g
(IFN-g) gene (Szabo et al., 2000, 2002). In order to determine
the role of T-bet in adipose tissue inflammation and insulin resis-
tance, we undertook studies in T-bet/ mice. Although it is pri-
marily known as the master transcription factor for Th1 cell
development, T-bet is also now recognized to be expressed
and have a critical role in cells of the innate immune system
(dendritic cells, innate lymphoid cells, and natural killer [NK] cells)
as well as in T cells (Garrett et al., 2007, 2009; Lugo-Villarino
et al., 2003; Townsend et al., 2004). In order to evaluate the
role of T-bet in the innate and adaptive immune systems, we
compared the metabolic phenotype of lymphocyte-deficient
mice (Rag2/) with that of lymphocyte-deficient mice that also
lacked T-bet in the innate immune system (Rag2/xT-bet/),
and performed reconstitution studies with T-bet-sufficient
or -deficient CD4+ T cells. A modest role for IFN-g in glucoseCell Metabolism 17, 520–homeostasis in obesity has been reported
(O’Rourke et al., 2012; Rocha et al., 2008;
Wong et al., 2011). However, in contrast
to T-bet, the role of IFN-g is not restricted
to immune cells. In order to address
the role of IFN-g as a potential mecha-
nism in the metabolic effects of T-bet
deficiency, we undertook studies in
IFN-g/ and IFN-g/xT-bet/ mice.
RESULTS
T-bet-Deficient Mice Display
Increased Visceral Adiposity and
Hyperleptinemia
Because obesity is associated with
increased Th1 cells in fat, we determinedthe impact of T-bet deficiency on the susceptibility to obesity
and its associated metabolic complications. Eight-week-old
male BALB/c T-bet-deficient mice (T-bet/) and age- and
sex-matched wild-type (WT) control mice were fed either a
low-fat diet (LFD) or HFD for 20 weeks. At 8 weeks of age, the
T-bet/ mice weighed significantly more than the WT mice
and this difference persisted after 20 weeks of LFD or HFD (Fig-
ure 1A); body length was similar between the genotypes (Fig-
ure S1A available online). Food intake was not significantly
different between the genotypes on the LFD. However, on the
HFD, the cumulative weekly food intake was significantly lower
in T-bet/ mice compared with WT (Figure 1B).
Although they are recognized to be less obesity prone
than mice on a BL/6 background, HFD feeding resulted in a
modest but significant increase in adipose tissue mass in both
T-bet/ and WT BALB/c mice, but T-bet/ mice were found
to have greater fat mass compared withWTmice, independently
of diet (Figure 1C). Furthermore, the increased fat mass
observed in T-bet/ mice was mainly due to an increase in533, April 2, 2013 ª2013 Elsevier Inc. 521
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Figure 2. T-bet-Deficient Mice Have Better
Glucose Tolerance and Are More Insulin
Sensitive
(A–C) Fasting glycemia (A) and insulin (B) levels
and HOMA-IR (C) in WT and T-bet/ mice after
14 weeks of LFD or HFD (n = 10–15).
(D–F) IPGTT from WT and T-bet/ mice after
18 weeks of (D) LFD feeding or (E) HFD feeding,
and (F) the corresponding area under the curve
(n = 8–14).
(G–I) ITTwithWT and T-bet/mice after 19weeks
of (G) LFD feeding or (H) HFD feeding, and (I) the
corresponding area under the curve (n = 8–14).
Data represent means ± SEM; *p < 0.05, **p < 0.01,
***p < 0.005, ###p < 0.005; two-way ANOVA.
Cell Metabolism
A Role for T-bet in Metabolic Physiologyintra-abdominal or visceral fat and, in particular, the perigonadal
white adipose tissue (PG WAT) depot, whereas the mass of the
subcutaneous WAT (SC WAT) depot was similar between
genotypes (Figure 1C). In both genotypes, HFD feeding was
associated with increased adipocyte size. However, adipocyte
diameter was also significantly greater in T-bet/ mice than in
WT mice irrespective of diet (Figures 1D and 1E). Consistent
with the increased fat mass observed with HFD feeding, both
genotypes displayed increased leptin levels on the HFD
compared with the LFD. However, T-bet/ mice had signifi-
cantly higher leptin levels than WT mice independently of diet,
in keeping with their greater fat mass (Figure 1F).
T-bet-Deficient Mice Display Improved Glucose
Homeostasis
Next we examined the impact of T-bet deficiency on glucose ho-
meostasis. Fasting glucose levels were not significantly different
between T-bet/ and WT mice (Figure 2A). However, despite
the increase in visceral fat mass observed in T-bet/ mice,
they were found to have significantly lower fasting (Figure 2B)
and fed (Figure S1B) insulin levels compared with WT mice.
We further evaluated glucose homeostasis by calculating the ho-
meostasis model of insulin resistance (HOMA-IR) index (Fig-
ure 2C) and by performing glucose and insulin tolerance tests
(ITTs). T-bet/ mice had better glucose tolerance than WT
mice on both the LFD and HFD (Figures 2D–2F). HFD feeding
worsened insulin sensitivity in both genotypes compared with
the LFDwhen evaluated by HOMA-IR (Figure 2C) or ITTs (Figures
2G–2I). However, LFD T-bet/ mice were significantly more in-522 Cell Metabolism 17, 520–533, April 2, 2013 ª2013 Elsevier Inc.sulin sensitive than WT mice and this
favorable metabolic phenotype associ-
ated with T-bet deficiency persisted
following HFD feeding (Figures 2G–2I).
T-bet-Deficient Mice Have Altered
Adipose Tissue Immune Cell
Infiltration and Cytokine Secretion
Adipose tissue comprises multiple cell
types in addition to adipocytes. Preadipo-
cytes, vascular endothelial cells, and
different immune cell populations are
well known to reside in the stromal
vascular fraction (SVF). Because it hasbeen shown that adipose tissue inflammation is linked to insulin
resistance in obesity, we evaluated the numbers and populations
of PG WAT immune cells in these mice by using flow cytometry
(Figure 3A). HFD feeding of both genotypes of mice did not in-
crease the number of CD45+ immune cells in the PG WAT depot
compared with LFD feeding. However, there were significantly
fewer CD45+ immune cells in the PG WAT depot of T-bet/
mice compared with WT mice, independently of diet (Figure 3B).
Further analyses revealed that the numbers of CD4+, CD8+, and
NK cells (CD3+ CD4+, CD3+ CD8+, and CD3 NKp46+, respec-
tively) were all significantly lower in adipose tissue from T-bet/
mice compared with WT mice, whereas the numbers of B cells
(B220+) and macrophages (CD11b+ F4/80+) were similar
(Figure 3B).
Alteration of immune cell populations is recognized to change
the inflammatory environment within adipose tissue, which in
turn can impact insulin sensitivity. We therefore measured the
spontaneous secretion of the cytokines IFN-g, TNFa, IL-10, IL-
1b, and IL-6 from the PG WAT depot following a 24 hr explant
organ culture. Consistent with the role of T-bet in directing Th1
cell development, IFN-g production from adipose tissue was
reduced in T-bet/ mice compared with WT mice. However,
the spontaneous release of TNF-a, IL-10, IL-1b, and IL-6 was
also lower in T-bet/ mice compared with WT (Figure 3C).
The Metabolic Phenotype Observed in T-bet Deficiency
Maps to the Adaptive Immune System
Although it is primarily recognized as the master transcription
factor in Th1 cell development, T-bet is now known to be
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Figure 3. T-bet-Deficient Mice Have Reduced Perigonadal Adipose Tissue Inflammation Independently of Diet
(A) Gating strategy used for flow cytometric analyses of SVF extracted from PG WAT and SC WAT. After the lymphocyte gate was defined with size (forward
scatter [FSC]) and granularity (side scatter [SSC]) parameters, CD45+ cells were gated and the expression of different markers (CD3, CD4, CD8, B220, and
NKp46) was used to identify the different populations. The same methodology was used to analyze the macrophage population after preadipocytes and
monocytes were gated with the use of FSC and SSC. Monocytes were identified by CD45 expression and the subsequent expression of CD11b and F4/80 was
used to identify macrophages.
(B) Flow cytometric analyses of SVF extracted from PG WAT of WT and T-bet/ mice on the LFD or HFD. The numbers of immune cells (CD45+), CD3+ CD4+
T cells, CD3+ CD8+ T cells, B cells (B220+), NK cells (CD3 NKp46+), and macrophages (CD11b+ F4/80+) are expressed per gram of PG WAT (n > 9).
(C) Concentrations of IFN-g, TNF-a, IL-10, IL-1b, and IL-6 secreted fromPGWAT andSCWAT cultures ofWT and T-bet/mice on the LFD or HFD expressed per
gram of adipose tissue (n = 8–13). Data represent means ± SEM; *p < 0.05, **p < 0.01, ***p < 0.005.
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Cell Metabolism
A Role for T-bet in Metabolic Physiologyexpressed and have a key role in cells of both the adaptive and
innate immune systems (Garrett et al., 2007, 2009; Lugo-Villarino
et al., 2003; Szabo et al., 2000, 2002; Townsend et al., 2004), but
it has no known role outside the immune system. Rag1/ and
Rag2/ mice lack an adaptive immune system (B, T, and NKT
cells) due to the absence of either Rag1 or Rag2, respectively.
To determine whether the glucose homeostasis and adipose tis-
sue phenotype conferred by T-bet deficiency mapped to the
adaptive or innate immune compartments, we generated
Rag2/ and T-bet/ double-knockout mice (Rag2/xT-bet/
mice). Importantly, this colony has been rederived in the absence
of colitogenic microflora and these mice do not develop sponta-
neous intestinal inflammation (Powell et al., 2012). We compared
the metabolic and adipose tissue phenotypes of Rag2/ and
Rag2/xT-bet/ mice on both the LFD and HFD. At baseline
there was no significant difference between the body weights
of Rag2/ and Rag2/xT-bet/ mice. Diet-induced weight
gain (Figure 4A) and body fat distribution (Figure S2A) were com-
parable in both genotypes. Leptin levels were also similar in both
genotypes of mice fed the LFD and incremented to a similar
extent with HFD feeding, suggesting that the susceptibility to
obesity of Rag2/xT-bet/ mice was no different from that of
Rag2/ mice (Figure 4B).
We next determined whether the absence of T-bet in the
innate immune system affected glucose homeostasis. HFD
feeding in both Rag2/ and Rag2/xT-bet/ mice resulted
in higher fasting glucose and insulin levels than were observed
on the LFD, but there was no significant difference in these
parameters between the genotypes (Figures 4C and 4D).
HOMA-IR worsened in both genotypes on the HFD, but there
was no difference between the genotypes on either diet (Fig-
ure S2B). Indeed, both glucose tolerance and insulin sensitivity
were similar in Rag2/ and Rag2/xT-bet/ mice fed either
the LFD or HFD, indicating that loss of T-bet in the innate immune
system does not significantly impact glucose homeostasis in this
model (Figures 4E–4J).
Adipose tissue immune cell numbers and subpopulations
were compared in PG WAT from Rag2/ and Rag2/xT-
bet/ mice (omitting B and T cell markers, as both of these ge-
notypes lack an adaptive immune system). Rag2/xT-bet/
mice had fewer adipose NK cells (CD3NKp46+ cells) compared
with Rag2/mice (Figure 4K), whereas the numbers of adipose
tissue macrophages (CD11b+ F4/80+) were similar between the
genotypes (Figure S2C). In these models, IFN-g is secreted
from innate immune cells and other cells, such as endothelium,
rather than from B and T lymphocytes. Given that T-bet defi-
ciency is associated with fewer NK cells (Soderquest et al.,
2011; Townsend et al., 2004), it was not surprising to find that
the secretion of IFN-g from cultured PG WAT explants was
significantly lower in Rag2/xT-bet/ mice compared with
Rag2/ mice (Figure 4L). Thus, the effect of T-bet deficiency
on adiposity and glucose homeostasis appears to be indepen-
dent of reduced IFN-g production and T-bet expression in the
innate immune system.
Reduced Energy Expenditure and Physical Activity
in T-bet-Deficient Mice
Because 6-month-old mice with T-bet deficiency were found
to have greater adipose mass but no increase in their food524 Cell Metabolism 17, 520–533, April 2, 2013 ª2013 Elsevier Inc.intake (Figures 1B and 1C), we investigated whether T-bet
deficiency was associated with an alteration in energy expen-
diture and/or activity. T-bet/ mice were found to have lower
energy expenditure in the dark phase (Figure 5A). This was
associated with a significant reduction in physical activity (Fig-
ure 5B) but no difference in the thermogenic response to an
energy challenge (Figure 5C) or change in the respiratory quo-
tient (Figure S3A).
Enhanced Insulin Sensitivity Despite Increased Visceral
Adiposity Is Present in Young T-bet-Deficient Mice
Because 6-month-old T-bet/ mice had greater visceral
adiposity but were more insulin sensitive than age-matched
WT mice, irrespective of whether they were fed the LFD or
HFD (Figures 1 and 2), we sought to determine whether the
absence of T-bet has a role in normal metabolic physiology by
investigating younger mice. Eight-week-old T-bet/ mice
weighed more than aged-matched WT mice, specifically due
to a significant increase in PG WAT rather than SC WAT depots
(Figures 5D and 5E). Adipocyte size was also already greater in
the young T-bet/ mice (Figure S3B). As with the 6-month-old
mice, young T-bet/mice were significantly more insulin sensi-
tive than WT mice (Figures 5G and 5H; Figure S3C), suggesting
that T-bet alters the relationship between adiposity and insulin
resistance even in young mice.
T-bet Deficiency Alters Immune Cell Populations and
Cytokine Secretion in Visceral, but Not Subcutaneous,
Adipose Tissue Depots
To further investigate the unusual observation of increased
visceral adiposity with improved insulin sensitivity, we
compared the immune cell populations and cytokine secretion
in PG WAT and SC WAT depots in young T-bet/ and WT
mice. Due to the expected large drop in the total number of
NK cells in T-bet deficiency (Townsend et al., 2004), we
observed an apparent compensatory increase in the proportion
of CD4+ T cells and B cells when expressed as a percentage of
all CD45+ immune cells (Figures S3D and S3E). However, the
absolute numbers of all major immune cell types (CD45+,
CD3+ CD4+, CD3+ CD8+, B220+, CD3 NKp46+, and CD11b+
F4/80+) were reduced in PG WAT from T-bet/mice compared
withWTmice (Figure 5I). In contrast, the numbers of all the major
immune cell types were similar between the genotypes in the SC
WAT depot (Figure 5J), although the number of CD3 NKp46+
tended to be lower in this depot also. Foxp3+ T cells were
recently proposed to contribute to metabolic homeostasis and
its dysregulation in obesity (Feuerer et al., 2009). We therefore
determined what proportion of CD4+ T cells were also Foxp3+
in these adipose tissue depots. There were significantly higher
proportions of CD4+ Foxp3+ T cells in the PG WAT of T-bet/
compared with WT mice (Figures 6A and 6B). In contrast,
consistent with our findings on the putative importance of
visceral adipose tissue CD4+Foxp3+ T cells in insulin resistance,
the proportions were similar in the SC WAT depot in both geno-
types (Figures 6A and 6B). Similar results were found with adi-
pose tissue expression of Foxp3 mRNA: expression was higher
in PG WAT from T-bet/ mice compared with WT mice, but no
difference was observed between genotypes in SC WAT Foxp3
expression (Figure 6C).
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(A) Body weights of Rag2/ and Rag2/xT-bet/ mice at the start (8 weeks old) and after 20 weeks of LFD and HFD.
(B–D) Fasting leptin (B), glycemia (C), and insulin (D) levels in Rag2/ and Rag2/xT-bet/ mice after 14 weeks of LFD or HFD.
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(n = 4). Data represent means ± SEM; *p < 0.05, **p < 0.01, ***p < 0.005. See also Figure S2.
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Figure 5. Reduced Activity, Increased Insulin Sensitivity, and Depot-Specific Differences in Immune Cell Numbers in Young T-bet–/– Mice
(A–C) Energy expenditure (A), locomotor activity (B), and thermogenic response to energy load (C) in 14-week-old WT and T-bet/ mice (n = 5–6).
(D–F) Body weights (D), weights of PG WAT and SCWAT fat pads (E), and fasting glycemia and insulin levels (F) in 8-week-old WT and T-bet/mice (n = 8–10).
(G and H) IPGTT (G) and ITT (H) from 6- to 7-week-old WT and T-bet/ mice (n = 8–9).
(I and J) Flow cytometric analyses of the SVF extracted from (I) PG WAT and (J) SC WAT of 8-week-old WT and T-bet/ mice. The numbers of immune cells
(CD45+), CD3+ CD4+ T cells, CD3+ CD8+ T cells, B cells (B220+), NK cells (CD3NKp46+), andmacrophages (CD11b+ F4/80+) are expressed per gram of PGWAT
and SC WAT (n = 9). Data represent means ± SEM; *p < 0.05, **p < 0.01, ***p < 0.005, ###p < 0.005; two-way ANOVA. See also Figures S3 and S4.
Cell Metabolism
A Role for T-bet in Metabolic PhysiologyAswehad observedwith oldermice, 24 hr ex vivo culture of PG
WAT from young T-bet/mice yielded significantly lower IFN-g,
TNF-a, IL-10, and IL-6 production compared with PG WAT from
WTmice. These genotypic differences in adipose tissue cytokine526 Cell Metabolism 17, 520–533, April 2, 2013 ª2013 Elsevier Inc.production were not seen following culture of the SCWAT depot
(Figures S4A–S4D). Not all adipocytokines were reduced in T-bet
deficiency: adipose tissue secretion of MCP-1 was found to be
similar between both genotypes as well as between both depots
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Figure 6. Role of CD4+ T Cells in the Improved Insulin Sensitivity Observed in T-bet–/– Mice
(A) Representative flow cytometric plots showing the percentage of CD4+ Foxp3+ T cells in PG WAT and SC WAT of 8-week-old WT and T-bet/ mice.
(B) Graphic representation of the percentage of FoxP3+ CD4+ T cells in PG WAT and SC WAT of 8-week-old WT and T-bet/ mice (n = 12).
(C) Relative gene expression levels of Foxp3 in the SVF of PGWAT and SCWAT fat pads from 8-week-old WT and T-bet/mice. The results were normalized to
the SVF of PG WAT from WT mice (n = 5).
(E–G) Relative gene expression levels of CXCR3 (D), CXCL9 (E), CXCL10 (F), and CXCL11 (G) in the SVF of PGWAT and SCWAT extracted from 8-week-old WT
and T-bet/ mice. The results were normalized to SVF of PG WAT from WT mice (n = 5).
(H) Body weights of Rag2/ recipient mice 3 weeks post CD4+ transfer.
(I and J) IPGTT (I) and ITT (J) from Rag2/ recipient mice 2 and 3 weeks post CD4+ transfer, respectively (n = 7–8).
(K) Flow cytometric analyses of the SVF fromPGWAT andSCWAT fat pads inRag2/ recipientmice. The numbers of CD3+CD4+ T cells are expressed per gram
of fat pad (n = 7–8). Data represent means ± SEM; *p < 0.05, **p < 0.01, ***p < 0.005. See also Figure S5.
Cell Metabolism
A Role for T-bet in Metabolic Physiology(Figure S4E). Thus, T-bet deficiency is associated with a favor-
able metabolic phenotype, even in young mice, and this is asso-
ciated with altered immune cell infiltration and spontaneous
cytokine secretion, particularly in PG WAT.CAltered Expression of T Cell Homing Molecules in
T-bet-Deficient Mice
T-bet specifies a transcriptional program that imprints the hom-
ing of T cells to proinflammatory sites (Lord et al., 2005). Weell Metabolism 17, 520–533, April 2, 2013 ª2013 Elsevier Inc. 527
Cell Metabolism
A Role for T-bet in Metabolic Physiologypreviously showed that the chemokine receptor CXCR3 is a
direct transcriptional target of T-bet (Jenner et al., 2009).
Because we found depot-specific differences in immune cell
numbers and types in T-bet/ mice, we evaluated CXCR3
expression in the PG WAT and SC WAT depots of T-bet/
and WT mice. CXCR3 expression in PG WAT was found to be
significantly lower in T-bet/ mice compared with WT mice.
However, although the expression of CXCR3 expression in SC
WAT was slightly lower in T-bet/ mice compared with WT
mice, the difference between the genotypes was not significant
in this depot (Figure 6D). We also compared the expression of
CXCR3 ligands CXCL9, CXCL10, and CXCL11 in the adipose tis-
sue depots. In the PG WAT, we found that the expression of
CXCL9 and CXCL10 was significantly altered in T-bet/ mice
compared with WT mice, whereas their expression was similar
in the SC WAT depot (Figures 6E and 6F). Expression of
CXCL11 in WT adipose tissue was consistently very low in
both depots, but was barely detectable in T-bet/ mice
(Figure 6G).
T-bet-Deficient CD4+ T Cells Improve Insulin Sensitivity
in Rag2–/– Mice
CD4+ T cell reconstitution in Rag1/ mice made obese and in-
sulin resistant with HFD feeding was previously reported to
reduce weight gain and improve glucose homeostasis (Winer
et al., 2009). This improvement was not observed following
CD8+ T cell transfer, suggesting a protective role for CD4+
T cells in this insulin-resistant, obese model (Winer et al.,
2009). Our data support a physiological role for T-bet deficiency
in the adaptive immune system, improving insulin sensitivity in
young mice even in the absence of HFD feeding. Therefore, we
investigated the impact of T-bet-deficient T cells on glucose ho-
meostasis by performing CD4+ T cell reconstitution studies in
young Rag2/ mice. Following transfer of T-bet-sufficient
(WT) or T-bet-deficient CD4+ T cells, there was no difference in
body weights (Figure 6H). However, we observed a modest but
significant improvement in the insulin sensitivity of the mice after
transfer of T-bet-deficient CD4+ T cells compared with WT CD4+
T cells, whereas there was no significant difference in their
glucose tolerance (Figures 6I and 6J). Consistent with a role for
T-bet in T cell trafficking (Lord et al., 2005), this difference in in-
sulin sensitivity was accompanied by fewer CD3+CD4+ cells (Fig-
ure 6K) and lower expression of IFN-g in the SVF detectable in
PG WAT (Figure S5).
IFN-g–/– and IFN-g–/–xT-bet–/– Mice Exhibit Similar
Glucose Homeostasis but Different Visceral Adiposity
To address the role of reduced IFN-g as a potential molecular
mechanism in the metabolic and adipose tissue phenotypes of
T-bet/ mice, we undertook studies in young IFN-g/ and
IFN-g/xT-bet/ mice. Body weight was similar between the
genotypes, although the mass of the PG WAT fat pad in
IFN-g/xT-bet/ was lower (Figures 7A and 7B). Adipocyte
size was similar between the genotypes (Figure 7C). There was
no genotypic difference between fasting glucose and insulin
levels or between glucose tolerance and insulin sensitivity (Fig-
ures 7E and 7F). We also found the numbers of the various im-
mune cell populations to be similar between the IFN-g/ and
IFN-g/xT-bet/mice, with the exception of significantly fewer528 Cell Metabolism 17, 520–533, April 2, 2013 ª2013 Elsevier Inc.NK cells (CD3 NKp46+) in the mice also lacking T-bet, as
expected (Figures 7G and 7H). Spontaneous cytokine secretion
from adipose tissue explant culture was also similar in IFN-g/
and IFN-g/xT-bet/ mice (Figure S6).
DISCUSSION
Immune cells are present in normal lean adipose tissue (Caspar-
Bauguil et al., 2005; Winer et al., 2009), but their role in metabolic
physiology is undefined. We have found that T-bet expression in
the adaptive immune system alters the relationship between
adiposity and insulin resistance, and this is associated with
changing immune cell populations in visceral adipose tissue.
T-bet/ mice have increased fat mass and higher leptin levels
compared with age-matched WT mice. This greater body fat
mass occurred without an increase in food intake, although we
did observe that T-bet/ mice have reduced energy expendi-
ture with reduced nocturnal physical activity. How T-bet
deficiency is able to influence physical activity is unclear. No
extraimmune function of T-bet has ever been described,
although its expression in the olfactory bulb has been reported
(Faedo et al., 2002; Mitsui et al., 2011). A T-bet ortholog was
also found very early in development in the mesoendoderm of
a marine invertebrate (Horton and Gibson-Brown, 2002). As
with any integrated physiological system, the consequences of
altered metabolic parameters such as cytokines, insulin, and
leptin are likely to have broader secondary effects on whole
animal physiology. The impact of T-bet deficiency on other
insulin-sensitive tissues such as muscle and liver, as well as
the gut immune system, may potentially contribute to the meta-
bolic phenotype of these mice; however, that is beyond the
scope of this paper.
Increased visceral adiposity is typically associated with insulin
resistance and other features of the metabolic syndrome (Tran
et al., 2008); therefore, the apparent uncoupling of visceral
adiposity and insulin resistance seen with T-bet deficiency,
even in young mice, was both unusual and unexpected. Fat
expansion has been reported without deleterious metabolic
effects in the context of transgenic overexpression of adiponec-
tin in the obese, leptin-deficient ob/ob mouse (Kim et al.,
2007) and peroxisome proliferator-activated receptor gamma
(PPAR-g) agonism. PPAR-g, the molecular target for the glita-
zone class of antidiabetic drugs, is a molecular mediator of
both adipogenesis and insulin sensitivity. Whether T-bet has a
role in adipogenesis and the downstream signaling pathways
of PPAR-g is unknown. However, in contrast to the case with
T-bet deficiency, the improved insulin sensitivity in these models
is accompanied by expansion of the subcutaneous adipose
depot but a reduction in the visceral adipose tissue depot.
This apparent dissociation of insulin resistance and adiposity
was accompanied by significantly reduced immune cell
numbers in PG WAT in T-bet/ mice. Many cell types have
been proposed to influence insulin resistance in obesity (Feuerer
et al., 2009; Nishimura et al., 2009; Ohmura et al., 2010; Winer
et al., 2009, 2011). Indeed, immune cell infiltration into the
visceral adipose tissue depot in particular is thought to be asso-
ciated with insulin resistance in obesity (Winer et al., 2009). The
anti-inflammatory action of Foxp3+ T cells (Tregs) has been
proposed to alter insulin sensitivity, as obesity is accompanied
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Figure 7. Similar Glucose Homeostasis and Adipose Immune Cell Infiltration in IFNg–/– and IFNg–/–xT-bet–/– Mice
(A–C) Body weights (A), weights of PG WAT and SC WAT fat pads (B), and fasting glycemia and insulin levels (C) in 8-week-old IFNg/ and IFNg/xT-bet/
mice (n = 8).
(D and E) IPGTT (D) and ITT (E) from 6- to 7-week-old IFNg/ and IFNg/xT-bet/ mice (n = 8).
(F) Representative H&E staining of PG WAT from IFNg/ and IFNg/xT-bet/ mice at 8 weeks of age. Adipocytes diameter measurement of PG WAT from
IFNg/ and IFNg/xT-bet/ mice at 8 weeks of age (n = 5).
(G and H) Flow cytometric analyses of the SVF extracted from (G) PG WAT and (H) SC WAT of 8-week-old IFNg/ and IFNg/xT-bet/mice. The numbers of
immune cells (CD45+), CD3+ CD4+ T cells, CD3+ CD8+ T cells, B cells (B220+), NK cells (CD3 NKp46+), and macrophages (CD11b+ F4/80+) are expressed per
gram of PG WAT and SC WAT (n = 8). Data represent means ± SEM; **p < 0.01, ***p < 0.005. See also Figure S6.
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Cell Metabolism
A Role for T-bet in Metabolic Physiologyby both a reduction in the proportion of this T cell population and
the development of insulin resistance (Feuerer et al., 2009). Our
observation that young, lean T-bet/mice had a higher propor-
tion of Foxp3+ T cells than control mice in the visceral adipose
tissue depot is consistent with a role for this cell subpopulation
in influencing insulin sensitivity. The significant difference in
visceral fat immune cells in T-bet/ mice compared with WT
mice is likely to contribute to the better insulin sensitivity
observed in these mice. Interestingly, in contrast to our findings
in PG WAT (with the exception of NK cells, which are known to
be reduced in T-bet deficiency; Soderquest et al., 2011), the
numbers and types of immune cells, including the proportion
of Foxp3+ T cells, in the SC WAT depot did not differ between
the genotypes.
We observed differences in the molecules responsible for
T cell trafficking in T-bet-deficient mice that may account for
the reduced number of immune cells observed in the adipose
tissue of T-bet/ mice. In this work we focused on the expres-
sion of CXCR3, which is a direct transcriptional target of T-bet
(Lord et al., 2005), and that of its ligands, CXCL9, CXCL10,
and CXCL11. These ligands can be induced in adipocytes
through the action of the IFN-g gene (Rocha et al., 2008), which
is also transcriptionally regulated by T-bet (Szabo et al., 2002).
However, there are many other chemokines expressed in adi-
pose tissue that lie downstream or may be independent of the
T-bet pathway that could potentially influence immune cell
trafficking.
We observed depot-specific differences in cytokine secretion
in T-bet-deficient mice that may contribute to their improved in-
sulin sensitivity. Spontaneous secretions from cultured adipose
tissue revealed that PG WAT production of the proinflammatory
cytokines IFN-g and TNF-a, as well as the anti-inflammatory
cytokine IL-10, were significantly lower in T-bet/ mice
compared with WT mice. This genotypic difference was not
observed in adipose tissue cultured from the SC WAT depot.
The proinflammatory cytokine TNF-a in particular is recognized
to have a negative effect on insulin signaling (Nieto-Vazquez
et al., 2008), although this inhibition can be overcome by IL-10
(Lumeng et al., 2007). IL-10 production was also reduced in
T-bet/ PG WAT. Tregs suppress immune function via multiple
mechanisms in addition to IL-10 production (Afzali et al., 2007).
Furthermore, given that the numbers of CD4+ cells and other im-
mune cells are reduced in this depot in T-bet/ mice, it is not
surprising that the levels of this and other cytokines are low. It
is likely that subtle quantitative and/or qualitative alterations in
the immune cell content of the PG WAT found in T-bet/ mice
affect the balance of these and other soluble mediators that
have a positive impact on insulin sensitivity.
The reduction of IFN-g secretion from T-bet/ adipose
tissue compared with that from WT was not unexpected.
IFN-g is the signature Th1 cytokine, although not all IFN-g pro-
duction is from immune cells and not all IFN-g gene expres-
sion is T-bet dependent (Lametschwandtner et al., 2004;
Szabo et al., 2002). IFN-g deficiency has been reported to
improve glucose homeostasis in diet-induced obesity (Rocha
et al., 2008; Wong et al., 2011; O’Rourke et al., 2012). Howev-
er, the immunological phenotypes of IFN-g deficiency and
T-bet deficiency are distinct: reducing IFN-g signaling in
mice by using IFN-g-deficient lines or blocking IFN-g paradox-530 Cell Metabolism 17, 520–533, April 2, 2013 ª2013 Elsevier Inc.ically worsens their susceptibility to autoimmune diseases
(which are thought to be Th1/Th17 driven), most notably
experimental allergic encephalomyelitis (EAE; Ferber et al.,
1996). In contrast, T-bet deficiency results in resistance to
EAE (Bettelli et al., 2004). The relationship between IFN-g
and T-bet is complex: T-bet is both upstream and down-
stream of IFN-g. Some IFN-g effects are T-bet dependent
and some are T-bet independent, and vice versa. In addition
to being a direct target of T-bet, IFN-g has an important role
in inducing the expression of T-bet in a STAT1-dependent
manner (Lighvani et al., 2001), indicating that some of the ef-
fects attributed to IFN-g may be due to its effect on T-bet
expression. We therefore addressed this complex molecular
interaction between T-bet and IFN-g in metabolic physiology
by performing additional experiments with IFN-g/ and
IFN-g/xT-bet/ mice. Because these genotypes were
found to have similar glucose homeostasis, it is likely that
IFN-g does play a role in the metabolic phenotype of these
mice. However, the significantly lower number of NK cells in
IFN-g/xT-bet/ mice (as is observed with T-bet deficiency;
Townsend et al., 2004) compared with IFN-g/ mice would
suggest that NK cells are not a major influence in glucose ho-
meostasis, at least in these models.
The similar bodyweights andmetabolic phenotype ofRag2/
and Rag2/xT-bet/mice also suggest that T-bet in the innate
immune system (dendritic cells, NK cells, and innate lymphoid
cells) is not amajor contributor to the favorablemetabolic pheno-
type seen in T-bet deficiency. IFN-g secretion in these B and T
lymphocyte-deficient models is not from the adaptive immune
system. Therefore, the lower IFN-g secretion from PG WAT
observed in Rag2/xT-bet/ mice is likely to be due the
reduced numbers of NK cells. Together with the studies in
IFN-g/ and IFN-g/xT-bet/mice, these data would indicate
an interaction between T-bet and IFN-g within the adaptive im-
mune system in the metabolic phenotype of the T-bet/ mice.
Furthermore, our finding that T-bet-deficient CD4+ T cells trans-
ferred to a young, lymphopenic host were able to confer a
modest but significant improvement in insulin sensitivity
compared with the transfer of WT CD4+ T cells provides proof
of concept that T-bet in the adaptive immune system is able to
influence metabolic physiology.
In summary, we have found that mice deficient for the Th1 cell
transcription factor T-bet have more intra-abdominal fat but are
more insulin sensitive than WT mice. Experiments in Rag2/
and IFN-g/ mice suggest that it is the absence of T-bet in
the adaptive immune system that confers this favorable meta-
bolic phenotype. Interestingly, T-bet deficiency is able to further
enhance insulin sensitivity in lean young mice that are already
insulin sensitive, indicating a role for T-bet in normal metabolic
physiology. This phenotype, which is associated with fewer
immune cells and altered cytokine secretion in visceral fat, per-
sisted in older mice and with diet-induced obesity. Although
human obesity is often associated with insulin resistance and
diabetes, this is not always the case (Karelis, 2008). Our data
suggest that obesity can be uncoupled from insulin resistance
through the absence of T-bet. Manipulation of the T-bet axis
may provide molecular targets for the development of new
strategies in the prevention and treatment of insulin resistance
and type 2 diabetes.
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Animals
Male BALB/c WT, T-bet/, Rag2/, Rag2/xT-bet/, IFN-g/, and
IFN-g/xT-bet/micewere bred in theKing’sCollege LondonBiological Ser-
vice Unit and housed in a specific pathogen-free environment. Studies were
carried out according to the UK Home Office guidelines. BL/6 mice are inher-
ently skewed immunologically toward Th1 responses (Schulte et al., 2008).
Theuseof theBALB/cbackgroundstrain for all themousemodels used in these
studiespotentially reduces thisbias andallows robustphenotypic comparisons
to bemade between genotypes. Diets (LFD [10% calories from fat, ref D12329]
or HFD [58%calories from fat, ref D12331]; ResearchDiet, NewBrunswick, NJ)
were started at the ageof 8weeks and continued for 20weeks,with free access
to water and food. Due to breeding constraints, age- and sex-matched mice
were studied in rolling groups of no fewer than three mice per genotype per
group at the same time of day, and because there was no significant difference
in the data obtained, the results were pooled. Nonfasted mice were sacrificed
by CO2 inhalation and blood was collected by terminal cardiac puncture.
Plasma was stored at 20C until it was analyzed. Tissues were snap-frozen
for further analysis or kept at 4C prior to cell extraction and organ culture.
In Vivo Studies
Mice were fasted overnight and tail vein blood was collected. Plasma samples
were stored at 20C until they were analyzed. Intraperitoneal glucose toler-
ance tests (IPGTTs, 1.5 g glucose/kg body weight; Sigma, Gillingham, UK)
and ITTs (1 U insulin/kg body weight, Actrapid; Novo Nordisk, Crawley, UK)
were performed as previously described (Howard et al., 2004). Energy expen-
diture and locomotor activity were measured in a manner similar to that previ-
ously described (Bellahcene et al., 2012; Stocker et al., 2007; Weir, 1949; see
Supplemental Experimental Procedures).
T Cell Transfer Experiment
Splenocytes were isolated from spleens of 8- to 9-week-old WT and T-bet/
chow-fed mice prior to enrichment for CD4+ lymphocytes by positive selection
(MACS; Miltenyi Biotech, Bergisch Gladbach, Germany). After enrichment, the
purity was typically >95%. CD4+ cells (53 106) were injected intraperitoneally
into 8-week-old chow-fed Rag2/ mice.
Isolation of Mononuclear Cells and Flow Cytometry
The SVF containing mononuclear cells and preadipocytes was extracted from
adipose tissue (Inouye et al., 2007) and cells were stained with antibodies con-
jugated to fluorochromes, CD45 (30-F1), CD3 (145-2C11), CD4 (GK1.5), CD8
(53-6.7), NKp46 (29A1.4), B220 (RA3-6B2), CD11b (M1/70), CD11c (N418),
F4/80 (BM8), and FoxP3 (FJK-16 s; eBiosciences, Hatfield, UK). 7-Amino-
actinomycin D (eBiosciences) or LIVE/DEAD fixable dead cell stain (Invitrogen,
Paisley, UK) was utilized to discriminate between live and dead cells. Samples
were acquired using a LSRII cytometer (Becton Dickinson, Franklin Lakes, NJ)
and data were analyzed using FlowJo software (Tree Star, Ashland, OR).
Organ Culture
Fresh PGWAT and SCWAT fat pads (100 mg) were cultured in 1 ml of RPMI
serum-free medium for 24 hr. The cytokines that were secreted were
measured after 24 hr by specific IFN-g, TNF-a, IL-1b, IL-6, IL-10, and
MCP-1 ELISAs (DuoSet ELISA Development kit, R&D, Abingdon, UK; and
ELISA Ready-SET-Go, eBioscience). Data are shown as the concentration
of cytokines secreted in 1 ml of culture medium per gram of fat pad.
Analysis of Metabolic Parameters
Blood glucose was measured using a glucometer (Statstrip Xpress; Nova
Biomedical, Runcorn, UK). Plasma insulin and leptin concentrations were
determined by ELISA (Crystal Chem, Downers Grove, IL) as previously
described (Howard et al., 2004). HOMA-IR was calculated from the product
of fasting serum glucose (mmol/l) and insulin (mU/ml), and then divided by
22.5 (Matthews et al., 1985).
RNA Extraction and Quantitative PCR Analysis
SVF RNA was extracted using Trizol reagent (Invitrogen), according to the
manufacturer’s protocol. After reverse transcription (High Capacity RNA-to-CcDNA Kit; Applied Biosystems, Warrington, UK), cDNA was quantified using
Taqman Gene Expression Assays (CXCR3 Mm99999054_s1, CXCL9
Mm00434946_m1, CXCL10 Mm00445235_m1, CXCL11 Mm00444662_m1,
and IFN-g Mm99999071_m1) with the ABI 7900HT Fast Real-Time PCR
System (Applied Biosystems). Relative gene expression levels were calculated
using the DDCt method (with b-actin used as the reference gene) and normal-
ized as indicated.
Immunohistochemical and Morphometric Analyses
Adipose tissue samples were fixed in formaldehyde solution and embedded in
paraffin according to standard procedures. Tissue sections (5 mm thick) were
stained with hematoxylin and eosin (H&E). Adipocyte diameters were
measured digitally in histological light-microscopic images (203) of adipose
tissue sections (n = 50 adipocytes/section, 1 section/animal, 5 animals/group)
using ImageJ software (NIH, Bethesda, MD).
Statistical Analyses
Results are expressed as mean ± SEM. Nonparametric data were analyzed
using a Mann-Whitney U test or two-way ANOVA as appropriate, using
GraphPad Prism 5.0 (GraphPad, San Diego, CA).
SUPPLEMENTAL INFORMATION
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